| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2001 | WO2001062257A2 Bupropion metabolites and methods of their synthesis and use |
| 08/30/2001 | WO2001062256A1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 08/30/2001 | WO2001062255A1 Antiviral azaindole derivatives |
| 08/30/2001 | WO2001062254A1 Patches containing buprenorphine hydrochloride |
| 08/30/2001 | WO2001062253A1 Compositions and methods for treatment of epilepsy |
| 08/30/2001 | WO2001062252A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062250A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 08/30/2001 | WO2001062249A1 Use of pramipexole for the treatment of addictive disorders |
| 08/30/2001 | WO2001062248A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives |
| 08/30/2001 | WO2001062247A1 Topical compositions containing thiazolium compounds and methods of using same |
| 08/30/2001 | WO2001062246A1 Method for treating neurodegeneration |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |
| 08/30/2001 | WO2001062244A1 Agents ameliorating sickness behaviors |
| 08/30/2001 | WO2001062243A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 08/30/2001 | WO2001062241A1 Method for the prevention or reduction of vascular access dysfunction |
| 08/30/2001 | WO2001062239A2 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | WO2001062238A2 Ppar gamma agonists for the treatment of liver inflammatory disorders |
| 08/30/2001 | WO2001062237A2 Compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus |
| 08/30/2001 | WO2001062236A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| 08/30/2001 | WO2001062235A2 A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 08/30/2001 | WO2001062234A2 Dosing regimen |
| 08/30/2001 | WO2001062233A2 Adenosine receptor modulators |
| 08/30/2001 | WO2001062231A1 Antibiotic composition with inhibitor |
| 08/30/2001 | WO2001062229A1 Therapeutic product, use and formulation thereof |
| 08/30/2001 | WO2001062228A1 Method for transdermal or intradermal delivery of molecules |
| 08/30/2001 | WO2001062227A2 Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease |
| 08/30/2001 | WO2001062222A2 Cosmetic composition, especially for use on aging and/or stressed skin |
| 08/30/2001 | WO2001062213A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same |
| 08/30/2001 | WO2001062207A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | WO2001062195A1 Antibiotic and antifungal compositions |
| 08/30/2001 | WO2001062156A1 Novel indocyanine dyes |
| 08/30/2001 | WO2001062102A1 Feed additives, forage and agents for animals, methods for the use thereof |
| 08/30/2001 | WO2001062086A1 Nutritional intervention composition for enhancing and extending satiety |
| 08/30/2001 | WO2001062082A2 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 08/30/2001 | WO2001027098A3 Method for producing cox-2 inhibitors |
| 08/30/2001 | WO2001026705A3 A dual adhesive transdermal drug delivery system |
| 08/30/2001 | WO2001025248A3 Design of high affinity rnase h recruiting oligonucleotide |
| 08/30/2001 | WO2001024842A3 Hybrid matrices and hybrid matrix mixtures |
| 08/30/2001 | WO2001014576A3 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 08/30/2001 | WO2001013927A3 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 08/30/2001 | WO2001013907A3 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 08/30/2001 | WO2001012606A3 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/30/2001 | WO2001012228A3 Compositions for treating viral infections, and methods therefor |
| 08/30/2001 | WO2001012199A3 Methoxyamine potentiation of temozolomide anti-cancer activity |
| 08/30/2001 | WO2001012195A3 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 08/30/2001 | WO2001010430A3 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 08/30/2001 | WO2001010378A3 Controlled release from copolymers of acrylic or methacrylic acid/l-dopa, acrylic or methacrylic acid/l-$g(a)-methyl dopa, acrylic or methacrylic acid/carbidopa and their combinations |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001007028A3 The use of retinoid receptor antagonists in the treatment of prostate carcinoma |
| 08/30/2001 | WO2001006985A3 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2000071510A3 INHIBITORS OF FACTOR Xa |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018598 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| 08/30/2001 | US20010018582 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 08/30/2001 | US20010018568 Method for transdermal administration of gp iib/iiia antagonist |
| 08/30/2001 | US20010018539 Antiallergens, antiinflammatory agents, antitumor agents |
| 08/30/2001 | US20010018538 Silylating the corresponding carbamate compound; alkylation |
| 08/30/2001 | US20010018531 Therapy for mammary or colon tumors |
| 08/30/2001 | US20010018530 Alzheimer's and Parkinson disease |
| 08/30/2001 | US20010018525 Modulating blood glucose concentration |
| 08/30/2001 | US20010018524 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 08/30/2001 | US20010018522 Neuropeptide y receptor ligand |
| 08/30/2001 | US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/30/2001 | US20010018458 Method for treating asthma utilizing optically pure ( R ) - salmeterol |
| 08/30/2001 | US20010018457 Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018455 Medicament and therapeutical method for treating idiopathic asthenozoospermia |
| 08/30/2001 | US20010018453 Reacting fatty ester with tosyl chloride or mesyl chloride |
| 08/30/2001 | US20010018451 Raloxifene, tamoxifen |
| 08/30/2001 | US20010018450 Amycomycin, a process for its production and its use as a pharmaceutical |
| 08/30/2001 | US20010018449 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/30/2001 | US20010018448 Hemorrhagic stroke |
| 08/30/2001 | US20010018447 Il-8 receptor antagonists |
| 08/30/2001 | US20010018445 Thalidomide |
| 08/30/2001 | US20010018444 Tropane-derivatives, their preparation and use |
| 08/30/2001 | US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 08/30/2001 | US20010018440 L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections |
| 08/30/2001 | US20010018439 Antidiabetic agents |
| 08/30/2001 | US20010018438 Nervous system disorders; psychological disorders |
| 08/30/2001 | US20010018436 Pyrimidine derivatives |
| 08/30/2001 | US20010018435 Prohormones; chemical intermediate in steroid metabolism in humans |
| 08/30/2001 | US20010018434 Administering an antiestrogen compound |
| 08/30/2001 | US20010018433 Administering a bisphosphonate compound; prostaglandin antagonist |
| 08/30/2001 | US20010018432 Skin disorders; acne, seborrhea |
| 08/30/2001 | US20010018431 Method for inhibiting bone resorption |
| 08/30/2001 | US20010018430 Anticancer agents, psoriasis, restenosis, atherosclerosis |
| 08/30/2001 | US20010018429 Neurotransmitter |
| 08/30/2001 | US20010018428 C-pyrazole A2A receptor agonists |
| 08/30/2001 | US20010018418 Method of promoting angiogenesis |
| 08/30/2001 | US20010018417 Of sodium lauryl sulfate, a buffering agent to provide acidic pH when the mixture is added to water, and colloidal silica; mixture added to animal feeds |
| 08/30/2001 | US20010018413 Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018090 Administering 1-deoxynojiriniglin or mulberry tea &/or plant powders/extracts with carbohydrate source inhibits bonding of disaccharides which are passed on to large intesine for excretion |
| 08/30/2001 | US20010018076 Anti-cancer agents isolated from buckwheat rhizomes (Fagospyrum cymosum); high powered liquid chromatography; purity; tannins |
| 08/30/2001 | US20010018075 Process for producing sustained-release preparation |
| 08/30/2001 | US20010018074 Admixing carrier particles with a solution of (R-(Z)-alpha-(methoxyimino)-alpha-(1-azabicyclo (2.2.2)oct-e-yl) acetonitrile monohydrochloride in water for treatment of dementia |
| 08/30/2001 | US20010018073 Drug delivery; steroids or hormones penetrate due to combination with destructuring agent and structuring agent in common matrix; useful in treatment of hypogonadism, infertility, or contraception |